Funded by the EU


JACIE's primary aim is to promote high quality patient care and laboratory performance in haematopoietic stem cell collection, processing and transplantation centres through the development of global standards and an internationally recognised system of accreditation.

In 1998, the European Society for Blood and Marrow Transplantation (EBMT) and the International Society for Cellular Therapy (ISCT) established the Joint Accreditation Committee-ISCT & EBMT. Based on the already existing FAHCT (later FACT) programme in the USA, the objective was to offer an inspection-based accreditation process in the field of haematopoietic stem cell (HSC) transplantation against established international standards. The Standards were approved by the EBMT General Assembly during the 1998 Annual Meeting in Courmayeur.

JACIE collaborates with the Foundation for the Accreditation of Cellular Therapy (FACT) to develop and maintain global standards for the provision of quality medical and laboratory practice in cellular therapy. Based on these standards, JACIE offers accreditation to transplant programmes in order to encourage health institutions and facilities performing HSC transplantation to establish and maintain quality management systems impacting on all aspects of their activities and to engage in continuous improvement.

For all purposes, JACIE is a committee of the EBMT. Members are appointed by and are accountable to the EBMT Board.

ISCT is represented through two members of the Committee.

© 2014 ARTHIQS

ARTHIQS (Grant agreement n. 20132101557886) has received funding from the European Commission in the framework of the Health Programme. The sole responsibility lies with the author and the Consumers, Health and Food Executive Agency is not responsible of any use that may be made of the information contained here.